The rollout of a type of genetic technology called a gene drive for tackling malaria could be edging closer after a lab study ...

ProBioGen and Spica Therapeutics Announce Collaboration on GlymaxX-Enhanced CLD for Spica’s Clinical Development Candidate ST101  BERLIN, Germany and BRUSSELS, Belgium, December 09, 2025 / Biotech ...

Silicon Valley and other high tech billionaires are investing millions in start-ups dedicated to creating genetically ...

In a landmark study published in Nature, scientists from the Ifakara Health Institute (IHI) and the National Institute for ...

By combining MED Institute's deep expertise in engineering, regulatory strategy, and clinical trials with Sus Clinicals' robust capabilities in developing large animal disease models, the two ...

Automated TCR-T production streamlines personalized immunotherapy, reducing patient burden and improving engineered T cell quality.

A cutting-edge therapy using base-edited immune cells is offering a major breakthrough for patients with one of the toughest ...

Researchers at the Department of Cell and Molecular Biology, Karolinska Institutet have captured the first detailed molecular ...

By manipulating this pathway, scientists may be able to tweak the immune response to treat cancers, autoimmune disorders, and more.

African Swine Fever Virus, ASFV, Viral Entry, Host Cell Invasion, CD163, Siglec-1, Macropinocytosis, Endosomal Escape, Immune Evasion, Signaling Pathways Share and Cite: Marcelino, K.B. and Fang, G.J.

Norovirus is the leading cause of gastroenteritis and is responsible for hundreds of thousands of deaths every year. However, ...

From rare diseases to chronic conditions, epigenetic editing unlocks new ways to control gene activity without altering the genetic code.